Results 241 to 250 of about 270,728 (301)

Case for caution in expanding attention deficit hyperactivity disorder prescribing

Internal Medicine Journal, EarlyView.
Abstract Expanding psychostimulant prescribing to general practitioners (GPs) addresses Australia's attention deficit hyperactivity disorder (ADHD) access crisis, but risks significant unintended consequences. This article highlights the cumulative risks of long‐term stimulant use and the danger of fragmented care models.
Max Hankin, Anthony Hew, Shalini Arunogiri, Thileepan Naren   +3 more
wiley   +1 more source

Revisiting the associations between cooking oils and survival among older people in China: A nationwide, community-based, prospective cohort study. [PDF]

PLoS One
Wang K, Ban C, Zhao L, Ruan H, Wang Z, Zheng Y, He S.   +6 more
europepmc   +1 more source

Healthcare costs of managing MAFLD are mostly driven by hospitalisation and advanced fibrosis: cost metabolic (dysfunction)‐associated fatty liver disease analysis from a tertiary‐care, multi‐disciplinary MAFLD clinic

Internal Medicine Journal, EarlyView.
Abstract Background and Aims Patients with metabolic (dysfunction)‐associated fatty liver disease (MAFLD) are frequently multimorbid, putting upward pressure on healthcare costs compared to other liver diseases. As Australian data are limited on expenditures in managing MAFLD, we evaluated hospital‐related costs and predictors of costs in patients ...
Natalie Ngu, Karl Vaz, Tobie Abrahams, Carmela Cosentino, John Lubel, Ammar Majeed, Stuart K Roberts, William Kemp   +7 more
wiley   +1 more source

Prevalence, incidence, mortality and causes of death in a large cohort of patients with rheumatoid arthritis: an Italian population-based study. [PDF]

RMD Open
Osele AG, Zen M, Salmaso L, Amidei CB, Fedeli U, Giollo A, Ragno D, Vesentini F, Salvato M, Ramonda R, Saia M, Doria A.   +11 more
europepmc   +1 more source

Influence of MASLD and MAFLD on long‐term extrahepatic cancer incidence and cancer mortality in regional Australia

Internal Medicine Journal, EarlyView.
Abstract Background and Aims Metabolic (dysfunction)‐associated steatotic liver disease (MASLD) has been linked to an increased risk of extrahepatic cancers. Whether MASLD or metabolic (dysfunction)‐associated fatty liver disease (MAFLD) is associated with an increased risk of extrahepatic cancer incidence or death in Australia is unknown. Methods This
Karl Vaz, William Kemp, Ammar Majeed, John Lubel, Dianna J Magliano, Kristen M Glenister, Lisa Bourke, David Simmons, Stuart K. Roberts   +8 more
wiley   +1 more source

Methodological concerns regarding mortality trends in CVD and Alzheimer's disease comorbidity. [PDF]

Am Heart J Plus
Qureshi AJ, Iftikhar M, Mahato RK.
europepmc   +1 more source

A Path-Specific Effect Approach to Mediation Analysis With Time-Varying Mediators and Time-to-Event Outcomes Accounting for Competing Risks. [PDF]

Stat Med
Domingo-Relloso A, Zhang Y, Wang Z, Suchy-Dicey AM, Buchwald DS, Navas-Acien A, Schwartz J, Berhane K, Coull BA, Valeri L.   +9 more
europepmc   +1 more source

Developing an explainable machine learning model using body composition to predict cardiovascular mortality in initial dialysis patients: a multicenter study. [PDF]

Front Physiol
Wang XX, Wei JX, Yu TK, Zheng GH, Cao JY, Li M, Wang Y, Hou SM, Xu J, Yang XD, Wang B.   +10 more
europepmc   +1 more source

National Trends in Cerebrovascular Disease-Related Mortality among Adults With Obesity in the United States, 1999-2020. [PDF]

Brain Behav
Hassan IN, Yaqub S, Ibrahim M, Abuassa N, Ibrahim M, Ahmed S, Khan A, Ashraf H.   +7 more
europepmc   +1 more source